Statistics for Leveraging copper chelators as targeted therapy for BRAFV600E mutant thyroid cancer
Total visits
views | |
---|---|
Leveraging copper chelators as targeted therapy for BRAFV600E mutant thyroid cancer | 110 |
Total visits per month
views | |
---|---|
March 2024 | 0 |
April 2024 | 0 |
May 2024 | 0 |
June 2024 | 1 |
July 2024 | 1 |
August 2024 | 0 |
September 2024 | 0 |
File Visits
views | |
---|---|
Xu_duke_0066D_14732.pdf | 161 |
Top country views
views | |
---|---|
United States | 7 |
Germany | 5 |
China | 3 |
France | 1 |
United Kingdom | 1 |
Top city views
views | |
---|---|
Beijing | 2 |
Saint Paul | 2 |
Ashburn | 1 |
Chaoyang | 1 |
Durham | 1 |
Houston | 1 |
Pfafftown | 1 |
Yulee | 1 |